NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX)

CUSIP: 64125C109

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
99,963,154
Total 13F shares
95,485,987
Share change
+651,709
Total reported value
$10,559,467,994
Put/Call ratio
68%
Price per share
$110.60
Number of holders
579
Value change
+$7,244,935
Number of buys
252
Number of sells
331

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F 13D/G
Company
12%
from 13D/G
14,782,722
$2,017,841,559 31 Dec 2024
VANGUARD GROUP INC
13F
Company
10%
10,119,641
$1,381,330,998 31 Dec 2024
13F
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
4.8%
from 13D/G
4,891,137
$667,654,967 31 Dec 2024
DODGE & COX
13D/G 13F
Company
5.6%
5,534,624
$585,341,834 $0 31 Mar 2025
CITADEL ADVISORS LLC
13F
Company
2.5%
2,538,109
$346,451,879 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.5%
2,489,397
$339,802,691 31 Dec 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
1.9%
1,896,891
$258,925,561 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.9%
1,875,062
$255,522,640 31 Dec 2024
13F
Bellevue Group AG
13F
Company
1.8%
1,820,000
$248,430,000 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
1.6%
1,573,297
$214,755,512 31 Dec 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.5%
1,490,513
$203,456,000 31 Dec 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.5%
1,457,425
$198,938,515 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
1.4%
1,371,186
$187,166,892 31 Dec 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
1.1%
1,070,096
$146,068,108 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.98%
983,799
$134,288,542 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.98%
981,939
$134,034,676 31 Dec 2024
13F
Invesco Ltd.
13F
Company
0.95%
949,512
$129,608,391 31 Dec 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.95%
944,738
$128,956,000 31 Dec 2024
13F
ORBIMED ADVISORS LLC
13F
Company
0.94%
938,120
$128,053,380 31 Dec 2024
13F
DSM CAPITAL PARTNERS LLC
13F
Company
0.93%
932,595
$127,299,219 31 Dec 2024
13F
BRAIDWELL LP
13F
Company
0.9%
901,790
$123,094,335 31 Dec 2024
13F
BROWN ADVISORY INC
13F
Company
0.9%
898,293
$122,616,993 31 Dec 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
0.89%
892,000
$121,758,000 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
0.87%
870,290
$118,794,538 31 Dec 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
0.86%
862,000
$117,663,000 31 Dec 2024
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.84%
843,902
$115,192,620 31 Dec 2024
13F
JENNISON ASSOCIATES LLC
13F
Company
0.82%
820,694
$112,024,734 31 Dec 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.79%
794,118
$108,399,391 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.76%
762,557
$104,089,031 31 Dec 2024
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Individual
0.75%
748,359
$102,151,000 31 Dec 2024
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
0.74%
737,772
$100,705,000 31 Dec 2024
13F
Rock Springs Capital Management LP
13F
Company
0.72%
720,500
$98,348,250 31 Dec 2024
13F
Pictet Asset Management Holding SA
13F
Company
0.61%
611,119
$83,417,744 31 Dec 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.61%
608,935
$83,119,630 31 Dec 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.58%
577,616
$78,844,584 31 Dec 2024
13F
IEQ CAPITAL, LLC
13F
Company
0.56%
557,904
$76,153,896 31 Dec 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.55%
550,157
$75,101,022 31 Dec 2024
13F
GW&K Investment Management, LLC
13F
Company
0.51%
514,082
$70,172,000 31 Dec 2024
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.51%
512,820
$69,999,930 31 Dec 2024
13F
Fiera Capital Corp
13F
Company
0.5%
499,109
$68,128,379 31 Dec 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.48%
480,565
$66,245,719 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.48%
484,034
$66,070,628 31 Dec 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.46%
461,782
$63,033,245 31 Dec 2024
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.45%
453,091
$61,846,922 31 Dec 2024
13F
UBS Group AG
13F
Company
0.42%
419,428
$57,251,924 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.42%
418,712
$57,154,188 31 Dec 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.41%
413,479
$56,441,001 31 Dec 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.39%
394,652
$53,869,998 31 Dec 2024
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
0.39%
393,710
$53,741,415 31 Dec 2024
13F
Hood River Capital Management LLC
13F
Company
0.36%
355,058
$48,465,417 31 Dec 2024
13F

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q1 2025

As of 31 Mar 2025, NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by 579 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,485,987 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Dodge & Cox, STATE STREET CORP, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Bellevue Group AG, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 583 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
596
Q1 2025 holders
579
Holder diff
-17
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.